Bartlett HIV/AIDS Review: September 15, 2004 Dr. Bartlett reviews the latest data on TDF vs d4T, FTC vs d4T, EFV vs ATZ, hyperlactatemia after NRTI switch, HAART and sexual risk-taking, cancer risk ...
Antiretroviral therapy has decreased the risk of lymphoma in the HIV-positive patient population, yet the incidence is still approximately 70-times greater than the incidence in the noninfected ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback